Opioid Addiction Treatment Programs Enhancement Act

Summary: Opioid Addiction Treatment Programs Enhancement Act This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to publish annually a report on the prevalence of substance use disorders and associated treatment within the Medicaid population in each state and U.S. territory.&nbsp;The report must include&nbsp;the number of substance use disorder diagnoses and the types of treatment received. The CMS must use specified data to compile the report and must make the data available to researchers and states. 

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Opioid Addiction Treatment Programs 
Enhancement Act''.

SEC. 2. T-MSIS SUBSTANCE USE DISORDER DATA BOOK.

    (a) In General.--Not later than the date that is 12 months after 
the date of enactment of this Act, the Secretary of Health and Human 
Services (in this section referred to as the ``Secretary'') shall 
publish on the public website of the Centers for Medicare & Medicaid 
Services a report with comprehensive data on the prevalence of 
substance use disorders in the Medicaid beneficiary population and 
services provided for the treatment of substance use disorders under 
Medicaid.
    (b) Content of Report.--The report required under subsection (a) 
shall include, at a minimum, the following data for each State 
(including, to the extent available, for the District of Columbia, 
Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, 
and American Samoa):
            (1) The number and percentage of individuals enrolled in 
        the State Medicaid plan or waiver of such plan in each of the 
        major enrollment categories (as defined in a public letter from 
        the Medicaid and CHIP Payment and Access Commission to the 
        Secretary) who have been diagnosed with a substance use 
        disorder and whether such individuals are enrolled under the 
        State Medicaid plan or a waiver of such plan, including the 
        specific waiver authority under which they are enrolled, to the 
        extent available.
            (2) A list of the substance use disorder treatment services 
        by each major type of service, such as counseling, medication 
        assisted treatment, peer support, residential treatment, and 
        inpatient care, for which beneficiaries in each State received 
        at least 1 service under the State Medicaid plan or a waiver of 
        such plan.
            (3) The number and percentage of individuals with a 
        substance use disorder diagnosis enrolled in the State Medicaid 
        plan or waiver of such plan who received substance use disorder 
        treatment services under such plan or waiver by each major type 
        of service under paragraph (2) within each major setting type, 
        such as outpatient, inpatient, residential, and other home and 
        community-based settings.
            (4) The number of services provided under the State 
        Medicaid plan or waiver of such plan per individual with a 
        substance use disorder diagnosis enrolled in such plan or 
        waiver for each major type of service under paragraph (2).
            (5) The number and percentage of individuals enrolled in 
        the State Medicaid plan or waiver, by major enrollment 
        category, who received substance use disorder treatment 
        through--
                    (A) a medicaid managed care entity (as defined in 
                section 1932(a)(1)(B) of the Social Security Act (42 
                U.S.C. 1396u-2(a)(1)(B))), including the number of such 
                individuals who received such assistance through a 
                prepaid inpatient health plan or a prepaid ambulatory 
                health plan;
                    (B) a fee-for-service payment model; or
                    (C) an alternative payment model, to the extent 
                available.
            (6) The number and percentage of individuals with a 
        substance use disorder who receive substance use disorder 
        treatment services in an outpatient or home and community-based 
        setting after receiving treatment in an inpatient or 
        residential setting, and the number of services received by 
        such individuals in the outpatient or home and community-based 
        setting.
    (c) Annual Updates.--The Secretary shall issue an updated version 
of the report required under subsection (a) not later than January 1 of 
each calendar year through 2024.
    (d) Use of T-MSIS Data.--The report required under subsection (a) 
and updates required under subsection (c) shall--
            (1) use data and definitions from the Transformed Medicaid 
        Statistical Information System (``T-MSIS'') data set that is no 
        more than 12 months old on the date that the report or update 
        is published; and
            (2) as appropriate, include a description with respect to 
        each State of the quality and completeness of the data and 
        caveats describing the limitations of the data reported to the 
        Secretary by the State that is sufficient to communicate the 
        appropriate uses for the information.

SEC. 3. MAKING T-MSIS DATA ON SUBSTANCE USE DISORDERS AVAILABLE TO 
              RESEARCHERS.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the ``Secretary'') shall publish in the 
Federal Register a system of records notice for the data specified in 
subsection (b) for the Transformed Medicaid Statistical Information 
System, in accordance with section 552a(e)(4) of title 5, United States 
Code. The notice shall outline policies that protect the security and 
privacy of the data that, at a minimum, meet the security and privacy 
policies of SORN 09-70-0541 for the Medicaid Statistical Information 
System.
    (b) Required Data.--The data covered by the systems of records 
notice required under subsection (a) shall be sufficient for 
researchers and States to analyze the prevalence of substance use 
disorders in the Medicaid beneficiary population and the treatment of 
substance use disorders under Medicaid across all States (including the 
District of Columbia, Puerto Rico, the Virgin Islands, Guam, the 
Northern Mariana Islands, and American Samoa), forms of treatment, and 
treatment settings.
    (c) Initiation of Data-Sharing Activities.--Not later than January 
1, 2019, the Secretary shall initiate the data-sharing activities 
outlined in the notice required under subsection (a).